Author Details
( * ) denotes Corresponding author
Underreporting of adverse drug reactions (ADRs) remains one of the major limitations of pharmacovigilance systems worldwide. Community pharmacists play an important role in detecting and reporting ADRs because of their close interaction with patients. This study investigated the barriers affecting ADR reporting and evaluated the impact of educational interventions among community pharmacists participating in a pharmacovigilance program in Oman. A prospective interventional study was conducted among seven community pharmacies between March 2020 and March 2022. Pharmacists participated in a structured educational workshop on pharmacovigilance and ADR reporting procedures. Data regarding reporting barriers, pharmacist participation, and ADR reporting trends were collected and analyzed. The most common barriers identified were concerns regarding patient confidentiality (35.7%), competing clinical responsibilities (19.8%), lack of ADR reporting forms (15.2%), and uncertainty regarding reporting procedures (9.2%). Educational interventions significantly improved pharmacist awareness, confidence, and reporting participation. A total of 700 ADR reports were documented during the study period following implementation of the intervention program. The study highlights the importance of pharmacist education and standardized reporting systems in strengthening pharmacovigilance practices. Simplified reporting processes, regular training programs, and supportive healthcare policies are essential to improving ADR reporting rates in community pharmacy settings.
Keywords
Pharmacovigilance; ADR reporting; Community pharmacists; Educational intervention; Drug safety; Reporting barriers
Abstract Views: 1
PDF Views: 3